# Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma

> **NCT01074060** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Refractory Multiple Myeloma
- Stage I Multiple Myeloma
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma

## Interventions

- **DRUG:** plerixafor
- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **PROCEDURE:** autologous hematopoietic stem cell transplantation
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01074060
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01074060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01074060, "Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01074060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*